Conference Symposia

After the COVID-19 tide: exploring novel approaches in Infectious diseases diagnostics from syndromic to immune testing.

ECCMID 2022 Lisbon, Portugal 

The uptake of COVID-19 vaccines has allowed many parts of the world to begin shifting from COVID-19 pandemic to endemic SARS-CoV-2. QIAGEN´s integrated symposium at ECCMID 2022 shares insights from the past 2 years of COVID-19, including themes from COVID-19's impact on respiratory pathogen epidemiology to assessing SARS-CoV-2 adaptive immunity utilising T-cell assays. Experts will review the paradigm shifts in molecular diagnostics from those focused-on influenza like illness (ILI) pathogens to more multiplexed solutions which provide an opportunity to bring together laboratorians and clinicians to improve patient outcomes and gain new perspective into the post pandemic world.